Search

Search Constraints

You searched for: Author/Creator Sy, Oumar

Search Results

1. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4‐year follow‐up and analysis of relative progression‐free survival from the randomized ELOQUENT‐2 trial. Issue 20 (11th September 2018)

3. The optic nerve sheath diameter as a useful tool for early prediction of outcome after cardiac arrest: A prospective pilot study. (June 2016)

4. Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study. Issue 3 (23rd February 2020)

8. Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase‐2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts. (27th April 2022)

9. Sustained low‐efficiency dialysis with regional citrate anticoagulation for patients with liver impairment in intensive care unit: A single‐center experience. Issue 2 (3rd August 2020)

10. Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth. (5th July 2017)